[Can the treatment of pulmonary superinfections in children with cystic fibrosis be maximized?].
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications* / Q000628:therapy; D006801:Humans; D011014:Pneumonia / Q000188:drug therapy* / Q000209:etiology; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy / Q000209:etiology
D000900:Anti-Bacterial Agents
Peut-on optimiser le traitement des surinfections pulmonaires chez l'enfant mucoviscidosique?